I thought JNJ's release on a Saturday was interesting. The flare up of these abstract/presentation notices is telling. JNJ's drug showed efficacy, but, from what I understand, is like shooting a BB gun at one bird and being excited you hit it. IDRA's drug is like shooting a shotgun at a covey. They (JNJ) want their price up while they can. Insider buying is always a good sign.
The earnestness to report by JNJ on Saturday will leave me dismayed if we don't hear something from IDRA in ... 8 hours or so.
JNJ showed 86% efficacy in their trial with their drug. We have to beat that. I think we did.
News 
Market Data 
Discover 
